Evidence map›Paper›PMID 37083758›Full record

ArticleAnalytical and bioanalytical chemistry2023

Quantification methods of determining brewer's and pharmaceutical yeast cell viability: accuracy and impact of nanoparticles.

Marco Eigenfeld, Leonie Wittmann, Roland Kerpes, Sebastian Schwaminger, Thomas Becker

Open access · hybridAbstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Biomass production optimization and quality assessment ofJournal of food science and technology · 2025
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Marco EigenfeldChair of Brewing and Beverage Technology, Technical University of Munich, TUM School of Life Science, Weihenstephaner Steig 20, 85354, Freising, Germany.
Leonie WittmannChair of Bioseparation Engineering, Technical University of Munich, TUM School of Engineering and Design, Boltzmannstr. 15, 85748, Garching, Germany.
Roland KerpesChair of Brewing and Beverage Technology, Technical University of Munich, TUM School of Life Science, Weihenstephaner Steig 20, 85354, Freising, Germany. roland.kerpes@tum.de.
Sebastian SchwamingerChair of Bioseparation Engineering, Technical University of Munich, TUM School of Engineering and Design, Boltzmannstr. 15, 85748, Garching, Germany.
Thomas BeckerChair of Brewing and Beverage Technology, Technical University of Munich, TUM School of Life Science, Weihenstephaner Steig 20, 85354, Freising, Germany.
Technical University of Munich · DE

Funding

Deutsche Forschungsgemeinschaft 441672360
6 · The paper itself

Abstract

For industrial processes, a fast, precise, and reliable method of determining the physiological state of yeast cells, especially viability, is essential. However, an increasing number of processes use magnetic nanoparticles (MNPs) for yeast cell manipulation, but their impact on yeast cell viability and the assay itself is unclear. This study tested the viability of Saccharomyces pastorianus ssp. carlsbergensis and Pichia pastoris by comparing traditional colourimetric, high-throughput, and growth assays with membrane fluidity. Results showed that methylene blue staining is only reliable for S. pastorianus cells with good viability, being erroneous in low viability (R

Indexed as

Methylene BlueSaccharomyces cerevisiaeCell SurvivalFluoresceinsPharmaceutical PreparationsSaccharomycescarboxyfluoresceindiacetateFluoresceinsMethylene BluePharmaceutical PreparationsMembrane fluidityNanoparticlesPhysiological statePlasma membraneViabilityYeast

Identifiers

PMID37083758
PMCPMC10287788
OpenAlexW4366602506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.